NCT01135290撤回早期 1 期
Evaluation of HP828-101 for Post Treatment Care Following a Chemical Peel or Laser Resurfacing
适应症
干预措施
相关药物
试验速览
- 阶段
- 早期 1 期
- 状态
- 撤回
- 发起方
- Healthpoint
- 试验地点
- 1
- 主要终点
- Physician and subject evaluation ratings of the signs and symptoms of facial skin during post-operative care.
研究概览
简要总结
This study tests two different approaches to the resolution of facial skin resurfacing.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Single (Care Provider)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The informed consent document and photography release must be read, signed, and dated by the subject or the subject's legally authorized representative before conducting any study procedures or exams. In addition, the informed consent and photography release document must be signed and dated by the individual who consents the subject before conducting Visit
- •A photocopy of the signed informed consent document must be provided to the subject, and the original signed document placed in the subject's chart.
- •Subjects 18 years of age or older, scheduled to undergo either a medium chemical peel with 35% TCA or a laser resurfacing. Subjects may be of either sex and of any race or skin type provided that their skin color, in the opinion of the Investigator, will not interfere with the study assessments.
- •Women of child-bearing potential (those who are not premenarchal, not surgically sterilized [hysterectomy or bilateral oophorectomy], or not post-menopausal) may participate in the study if they meet all of the following conditions:
- •they are not breast feeding
- •undertake a pregnancy test, which must be negative
- •they do not intend to become pregnant during the study
- •they are using adequate birth control methods and they agree to continue using those methods for the duration of the study
- •Adequate birth control methods are defined as: hormonal-topical, oral, implantable, or injectable contraceptives; mechanical-spermicide in conjunction with a barrier such as a condom or diaphragm; IUD; or, surgical sterilization of partner. For non-sexually active females, abstinence may be regarded as an adequate method of birth control; however, if the subject becomes sexually active during the study, she must agree to use an adequate birth control method as described above for the remainder of the study.
- •NOTE: Women who have had a bilateral tubal ligation are not considered to have been surgically sterilized and must agree to the conditions as specified above.
- •Willing and able to make all required study visits.
- •Able to follow instructions.
- •Undergo a medium grade chemical peel or fractional resurfacing.
排除标准
- •Contraindications or hypersensitivity to the use of the study medications or their components (e.g., balsam of Peru, castor oil, or phenoxyethanol).
- •Therapy with another investigational agent within thirty (30) days of Visit 1, or during the study.
- •Have taken anticoagulants (blood thinners, including aspirin) within two weeks.
- •Current smoker.
- •Use of oral isotretinoin during the past 12 months, systemic steroids, topical retinoids, or topical corticosteroids within the month prior to the study.
- •Have any congenital skin disorder which affects keratinocytes, elastin, or collagen.
- •Have any dermatologic disease which may be aggravated or provoked by the wounding procedure.
- •Are at risk of keloid or hypertrophic scar formation based on personal or family history, or skin exam.
- •Have any skin disorder which causes delayed healing.
- •Have any systemic condition that would compromise skin healing.
- •The Medical Monitor may declare any subject ineligible for a valid medical reason.
研究组 & 干预措施
B
Other
干预措施: Aquaphor (Drug)
A
Active Comparator
干预措施: HP828-101 (Drug)
结局指标
主要结局
Physician and subject evaluation ratings of the signs and symptoms of facial skin during post-operative care.
时间窗: 84 Days
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Comparison of Two Resurfacing Prostheses in the Treatment of Osteoarthritis of the ShoulderOsteoarthritisNCT00408096University of Aarhus32
已完成
不适用
Evaluation of the Effects of HP828-101 Versus Standard of Care in the Management of Partial or Full Thickness WoundsDiabetic Foot UlcersPressure UlcersNCT00971048Healthpoint88
已完成
4 期
Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)Facial RhytidesCrow's Feet LinesGlabellar LinesNasolabial FoldNCT02176356Allergan116
已完成
不适用
Post-Procedural Biotech Cellulose MaskTemperature Change, BodyNCT06065332Siperstein Dermatology15
已完成
不适用
Clinical Case Series Evaluating Skin Wellness SystemMoisture-associated DermatitisFungal Infection in Perineal AreaNCT01724229GM Associates20